Callan JMB Inc. (NASDAQ:CJMB) Short Interest Down 69.5% in July

Callan JMB Inc. (NASDAQ:CJMBGet Free Report) was the recipient of a significant decrease in short interest in the month of July. As of July 15th, there was short interest totaling 26,183 shares, a decrease of 69.5% from the June 30th total of 85,963 shares. Currently, 1.8% of the shares of the company are sold short. Based on an average daily volume of 59,808 shares, the days-to-cover ratio is currently 0.4 days.

Callan JMB Stock Down 22.1%

CJMB stock traded down $0.60 during mid-day trading on Tuesday, reaching $2.10. 379,898 shares of the stock traded hands, compared to its average volume of 2,562,201. The firm has a market capitalization of $11.87 million, a PE ratio of -1.00 and a beta of -0.26. The business has a 50-day moving average of $0.93 and a two-hundred day moving average of $1.37. Callan JMB has a 52 week low of $0.65 and a 52 week high of $5.61.

Callan JMB (NASDAQ:CJMBGet Free Report) last posted its quarterly earnings data on Friday, May 15th. The company reported ($0.59) EPS for the quarter. Callan JMB had a negative return on equity of 285.36% and a negative net margin of 184.70%.The business had revenue of $1.11 million during the quarter.

Institutional Trading of Callan JMB

An institutional investor recently raised its position in Callan JMB stock. Creative Planning grew its position in Callan JMB Inc. (NASDAQ:CJMBFree Report) by 41.7% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 170,008 shares of the company’s stock after acquiring an additional 50,000 shares during the period. Creative Planning owned 3.79% of Callan JMB worth $830,000 at the end of the most recent reporting period.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Callan JMB in a report on Wednesday, April 29th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, Callan JMB presently has a consensus rating of “Sell”.

View Our Latest Stock Analysis on Callan JMB

About Callan JMB

(Get Free Report)

Callan JMB is a vertically integrated logistics and fulfillment company which provides thermal management logistics solutions to the life sciences industry through a combination of proprietary packaging, information technology and specialized cold chain logistics knowhow. We provide a system that utilizes advanced predictive technology to revolutionize the supply chain by guaranteeing the safety, effectiveness, and potency of every product handled to ensure product integrity, and to provide immediate response in time-sensitive industries while ensuring environmental responsibility.

See Also

Receive News & Ratings for Callan JMB Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Callan JMB and related companies with MarketBeat.com's FREE daily email newsletter.